会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • 5-PHENYL-THIAZ0L-2-YL-UREA DERIVATIVES AND USE AS PI3 KINASE INHIBITORS
    • 5-PHENYL-THIAZ0L-2-YL-UREA衍生物和用作PI3激酶抑制剂
    • WO2007134827A8
    • 2009-01-08
    • PCT/EP2007004500
    • 2007-05-21
    • NOVARTIS AGBUDD EMMAHAYLER JUDY FOXBRUCE IANLEGRAND DARREN MARKCOX BRIAN
    • BUDD EMMAHAYLER JUDY FOXBRUCE IANLEGRAND DARREN MARKCOX BRIAN
    • C07D277/48A61K31/427A61P11/00C07D417/12
    • C07D277/48C07D417/12
    • The present invention concerns a compound of formula Ia wherein: Ra * is hydrogen or C1-C4-alkyl; Rb* is -(C1-C4-alkylene)-Y-C1-C4-haloalkyl or -(C1-C4-alkylene)-Y-C1-C4-hydroxyalkyl; Y represents -CONH- or a five membered heteroaryl group. R2* is C1-C4-alkyl or halogen; R3* is halo, -SO2-CH3, -SO2-CF3, carboxy, -CO-NH2, -CO-di(C1-C8-alkyl)amino, or a 5- or 6- membered heterocyclic ring having one or more ring hetero atoms selected from the group consisting of oxygen, nitrogen and sulphur, that ring being optionally substituted by halo, cyano, oxo, hydroxy, carboxy, nitro, C3-C8-cycloalkyl, C1-C8-alkylcarbonyl, C1-C8-alkoxy optionally substituted by aminocarbonyl, or C1-C8-alkyl optionally substituted by hydroxy, C1- C8-alkoxy, C1- C8-alkylamino or di(C1- C8-alkyl)amino; R4* is hydrogen, halo, -SO2-CH3, nitrile, C1- C8-haloalkyl, imidazolyl, C1- C8-alkyl, -NR8*R9*, or -SO2-NR8*R9*; and R5* is hydrogen, halogen or C1- C8-alkyl; R8* and R9* are independently hydrogen, amino, C1- C8-alkylamino, di(C1- C8-alkyl)amino, or CC1- C8-alkyl optionally substituted by hydroxyl; or a pharmaceutically acceptable salt, or solvate thereof, to compositions and use of the compounds in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase.
    • 本发明涉及式Ia化合物,其中:Ra *是氢或C 1 -C 4 - 烷基; Rb *是 - (C1-C4-亚烷基)-Y-C1-C4-卤代烷基或 - (C1-C4-亚烷基)-Y-C1-C4-羟基烷基; Y表示-CONH-或五元杂芳基。 R2 *是C1-C4-烷基或卤素; R3 *是卤素,-SO2-CH3,-SO2-CF3,羧基,-CO-NH2,-CO-二(C1-C8-烷基)氨基或具有一个或多个环的5-或6-元杂环 氰基,氧代,羟基,羧基,硝基,C 3 -C 8 - 环烷基,C 1 -C 8 - 烷基羰基,C 1 -C 8 - 烷氧基任选地被选自氧,氮和硫的杂原子 被氨基羰基取代,或任选被羟基取代的C 1 -C 8 - 烷基,C 1 -C 8 - 烷氧基,C 1 -C 8 - 烷基氨基或二(C 1 -C 8 - 烷基)氨基; R4 *是氢,卤素,-SO2-CH3,腈,C1-8-卤代烷基,咪唑基,C1-8-烷基,-NR8 * R9 *或-SO2-NR8 * R9 *; 和R5 *是氢,卤素或C 1 -C 8 - 烷基; R 8 *和R 9 *独立地为氢,氨基,C 1 -C 8 - 烷基氨基,二(C 1 -C 8 - 烷基)氨基或任选被羟基取代的C 1 -C 8烷基; 或其药学上可接受的盐或溶剂合物,用于治疗通过抑制磷脂酰肌醇3-激酶而变质的疾病的组合物和用途。
    • 9. 发明申请
    • METHODS AND SYSTEMS FOR FORMING OPHTHALMIC LENS MOLD ASSEMBLIES
    • 形成眼镜镜模组装的方法和系统
    • WO2008062321A2
    • 2008-05-29
    • PCT/IB2007004339
    • 2007-05-30
    • COOPERVISION INT HOLDING CO LPBRUCE IANBAILEY STUARTOAG ROBSAUNDERS STEPHEN
    • BRUCE IANBAILEY STUARTOAG ROBSAUNDERS STEPHEN
    • G06F19/00
    • B29D11/005B29C33/202B29L2011/0041Y10S425/808
    • Methods and systems are provided for making an ophthalmic lens. The present methods and systems are effecting in coupling two mold sections together at two or more discrete regions. Embodiments of the methods and systems form a bore that extends completely through one of the mold sections and only partially through the other mold section. During formation of the bore, the mold material in proximity to the bore being formed becomes molten and diffuses from the bore. A portion of the molten mold material is provided at a contact point between the two mold sections and when the molten material cools, the material forms a spot weld between the mold sections. By forming multiple hollow spot welds in a mold assembly, the two mold sections can be securely coupled to each other during the manufacture of an ophthalmic lens, such as a silicone hydrogel contact lens.
    • 提供了用于制造眼科镜片的方法和系统。 目前的方法和系统正在两个或更多个离散区域将两个模具部分联接在一起。 方法和系统的实施例形成了一个完全穿过其中一个模具部分并且仅部分地穿过另一个模具部分的孔。 在孔的形成期间,靠近所形成的孔的模具材料变得熔化并且从孔扩散。 熔融模具材料的一部分设置在两个模具部分之间的接触点处,并且当熔融材料冷却时,该材料在模具部分之间形成点焊。 通过在模具组件中形成多个中空点焊,在制造眼用透镜(例如硅酮水凝胶隐形眼镜)期间,两个模具部分可以彼此牢固地联接。